Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

Pfizer Inc. Buy: market overreacts to Q4 loss and 2026 guidance; oncology-led growth, 102-candidate pipeline, and dividend offer upside. Click for this PFE update.

Intuitive Surgical looks like a long-term buy: strong Da Vinci 5 adoption, expanding FDA use cases, and multiyear-low valuation. Click here to read more.